Comparison of inflammatory events in skin sites with and without cutaneous late-phase reactions after prominent immediate IgE-mediated responses

Journal of Allergy and Clinical Immunology

Volumn 101, Issue 1, 1998, Pages 110-115

  Zweiman, Burton ^a,b   Moskovitz, Anne R ^a   Von Allmen, Carolyn ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cytokines; IgE mediated responses; Inflammatory cells; Late phase reactions

Indexed keywords

CYTOKINE; EOSINOPHIL CATIONIC PROTEIN; HISTAMINE; IMMUNOGLOBULIN E; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; LACTOFERRIN; POLLEN ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ALLERGY; ARTICLE; CLINICAL ARTICLE; HISTAMINE RELEASE; HUMAN; IMMUNOPATHOGENESIS; INFLAMMATORY CELL; PRIORITY JOURNAL; SKIN TEST; T LYMPHOCYTE ACTIVATION;

EID: 0031890104     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(98)70201-5     Document Type: Article

References (24)

1. Zweiman B. The late-phase reaction: role of IgE, its receptor and cytokine. Curr Opin Immunol 1993;5:950-5.
2. Massey WA. Pathogenesis and pharmacologic modulation of the cutaneous late phase reaction. Ann Allergy 1993;71:578-84.
3. Charlesworth EN. Late phase inflammation: influence on morbidity. J Allergy Clin Immunol 1996;98:S291-7.
4. Zweiman B, Kaplan AP, Joseph K, Moskovitz AR. Cytokine levels and inflammatory responses in developing allergic late phase reactions in the skin. J Allergy Clin Immunol 1997;100:104-9.
5. Shalit M, Schwartz LB, von Allmen C, Atkins PC, Lavker RM, Zweiman B. Release of histamine and tryptase during continuous and interrupted cutaneous challenge with allergen in humans. J Allergy Clin Immunol 1989;50:41-51.
6. Zweiman B, Kucich U, Shalit M, von Allmen C, Moskovitz AR, Weinbaum G, et al. Release of lactoferrin and elastase in human allergic skin reactions. J Immunol 1990;144:3953-60.
7. Atkins PC, Schwartz LB, Adkinson NF, von Allmen C, Valenzano M, Zweiman B. In vivo antigen-induced cutaneous mediator release: simultaneous comparisons of histamine, tryptase and prostaglandin D2 release and the effect of oral corticosteroid administration. J Allergy Clin Immunol 1990;86:360-6
8. Charlesworth EN. Role of basophils and mast cells in acute and late phase reactions in the skin. Chem Immunol 1995;62:84-107.
9. Zweiman B, Atkins PC, von Allmen C, Gleich GJ. Release of eosinophil granule proteins during IgE-mediated allergic skin reactions. J Allergy Clin Immunol 1991;87:984-91.
10. Martin LB, Kita H, Leiferman K, Gleich GJ. Eosinophils in allergy: role in disease degranulation and cytokines. Int Arch Allergy Immunol 1996;109:207-15.
11. Taborda-Barata L, Jacobsen M, Walker S, Njuki F, Ying S, Randev P, et al. Effect of cetirizine and prednisolone on cellular infiltration and cytokine mRNA expression during allergen-induced late cutaneous responses. Clin Exp Allergy 1996;26:68-78.
12. Bochner BS, Charlesworth EN, Lichtenstein LM, Deerse CP, Gilles S, Dinarello CA, et al. Interleukin-1 is released at sites of human cutaneous allergic reactions. J Allergy Clin Immunol 1990;86:830-9.
13. Lee CE, Newland MW, Teaford GH, Villacis BF, Dixon PS, Valtheer S, et al. Interleukin-6 is released with the cutaneous response to allergen challenge in atopic individuals. J Allergy Clin Immunol 1992;89:1010-20.
14. Talbot SF, Atkins PC, Goetzl EJ, Zweiman B. Accumulation of leukotriene C4 and histamine in human allergic skin reactions. J Clin Invest 1985;76:650-6.
15. Shalit M, Valone FH, Atkins PC, Ratnoff WD, Goetzl EJ, Zweiman B. Late appearance of phospholipid platelet activating factor and leukotriene B4 in human skin after repeated antigen challenge. J Allergy Clin Immunol 1989;83:691-6.
16. Atkins PC, Zweiman B, Littman B, Presti C, von Allmen C, Moskovitz AR, et al. Products of arachidonic acid metabolism and the effects of cyclooxygenase inhibition upon ongoing cutaneous allergic reactions in humans. J Allergy Clin Immunol 1995:95:742-7.
17. Zeng L, Goetzl EJ, Zweiman B. Release and activation of matrix metalloproteinase-9 in the late-phase of human cutaneous allergic reactions [abstract]. J Allergy Clin Immunol 1997;99:S37.
18. Atkins PC, Kaplan AP, von Allmen C, Moskovitz AR, Zweiman B. Activation of the coagulation pathway during ongoing allergic cutaneous reactions in humans. J Allergy Clin Immunol 1992;89:552-9.
19. DeShazo RO, Levinson AI, Dvorak HF, Davis RW. The late-phase skin reaction: evidence for activation of the coagulation system in an IgE-dependent reaction in man. J Immunol 1979;122:692-8.
20. Lemanske RF Jr, Kaliner MA. Late phase reactions. In: Reed CE, Ellis EF, Adkinson NF Jr, Yunginger JW, Busse WW, editors. Allergy, principles and practice. St. Louis: Mosby-Year Book; 1993. p. 320-61.
21. Schroeder JT, MacGlashan DW Jr. New concepts: the basophil. J Allergy Clin Immunol 1997;99:429-33.
22. Tsciopoulos A, Hamid Q, Haczlea A, Jacobson MR, Durham SR, North J, et al. Kinetics of cell infiltration and cytokine messenger RNA expression. J Allergy Clin Immunol 1994;94:764-72.
23. Zweiman B, Atkins PC, Moskovitz AR, von Allmen C, Ciliberti M, Grossman S. Cellular responses during immediate, developing, and established late-phase allergic cutaneous reactions: effects of cetirizine. J Allergy Clin Immunol 1997;100:341-7.
24. Kay AB, Ying S, Varney V, Gaga M, Durham SR, Moqbel R, et al. Messenger RNA expression of the cytokines cluster IL-3, 11-4 and GM-CSF in allergen-induced late phase reactions in atopic subjects. J Exp Med 1991;173:775-8.